Cargando…
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Hematologic malignancies (HMs) pose a serious threat to patients’ health and life, and the five-year overall survival of HMs remains low. The lack of understanding of the pathogenesis and the complex clinical symptoms brings immense challenges to the diagnosis and treatment of HMs. Traditional thera...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290401/ https://www.ncbi.nlm.nih.gov/pubmed/37353849 http://dx.doi.org/10.1186/s13045-023-01460-2 |